Gene · 7030
TFE3: transcription factor binding to IGHM enhancer 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TFE3: transcription factor binding to IGHM enhancer 3. Genes, record 7030. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7030
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P19532 | Transcription factor E3 | 575 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents25
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 67424 | P19532 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 4942 | P19532 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15765 | P19532 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 4942 | P19532 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15765 | P19532 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15765 | P19532 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15604 | P19532 | Espacenet |
| US 11884978 B2 | 2024-01-30 | 761 | P19532 | Espacenet |
| US 11860162 B2 | 2024-01-02 | 1258 | P19532 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 89858 | P19532 | Espacenet |
1 to 10 of 25
See all 25 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,154
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TFE3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 73 | 2025 |
| ZIABC011028 | Clinical Studies of the Molecular Genetic Basis of Kidney Cancer | 27 | 2025 |
| ZIDBC011089 | Clinical Nursing and Data Management Core | 24 | 2025 |
| ZIABC011043 | Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene | 23 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 22 | 2025 |
| ZIAHL006151 | Lysosome biogenesis and homeostasis | 22 | 2025 |
| P50CA217694 | SPORE in Soft Tissue Sarcoma | 20 | 2025 |
| ZIABC011038 | Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene | 20 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 11 | 2025 |
| R01AR043369 | MITF from control of pigmentation to melanoma risk | 11 | 2025 |
1 to 10 of 1,154Source NIH's project files
See all 1,154 nih grantsPapers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunoreactivity of GPNMB (glycoprotein nonmetastatic melanoma protein B) across the spectrum of uterine mesenchymal tumours. | Histopathology | 2026 | 42791032 | PubTator, text mining | PubMed |
| mTORC1-TFEB/TFE3 signaling is associated with bile acid diversification during hepatic metabolic adaptation. | Sci Adv | 2026 | 42789715 | PubTator, text mining | PubMed |
| Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma. | Nat Commun | 2026 | 42786155 | PubTator, text mining | PubMed |
| Emerging patterns of kidney cancer in young adults: where do we stand? | Crit Rev Oncol Hematol | 2026 | 42764100 | PubTator, text mining | PubMed |
| A partial response to atezolizumab in alveolar soft part sarcoma with near-complete resolution of extensive pulmonary metastases: a case report. | Front Oncol | 2026 | 42761021 | PubTator, text mining | PubMed |
| Adult Mixed Epithelial and Stromal Tumor of the Kidney Harbors Recurrent Whole Chromosome 12 Gain. | Am J Surg Pathol | 2026 | 42750419 | PubTator, text mining | PubMed |
| Clinical Outcomes, Treatment Patterns, and Molecular Heterogeneity of TFE3-Rearranged Renal Cell Carcinoma: A Multicenter Real-World Study. | Cancer Med | 2026 | 42726730 | PubTator, text mining | PubMed |
| Case Report: Acquired CDKN2A/B deletion and mTOR inhibitor resistance in TSC2-mutant metastatic epithelioid angiomyolipoma. | Front Med (Lausanne) | 2026 | 42712743 | PubTator, text mining | PubMed |
| [Birt-Hogg-Dubé syndrome-associated renal tumors: a clinicopathological and molecular genetic analysis of ten cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 42706109 | PubTator, text mining | PubMed |
| EIF1 coordinates transcriptomic and splicing networks associated with cell cycle dysregulation in diabetic retinopathy. | PLoS One | 2026 | 42691050 | PubTator, text mining | PubMed |
1 to 10 of 3,398
See all 3,398 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7030
GET https://conductscience.org/api/genes/v1/7030/patents?page=2